Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

A comparison of cervical and vaginal human papillomavirus.

Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD.

Sex Transm Dis. 2007 Nov;34(11):849-55.

2.

Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.

Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL.

Int J Cancer. 2010 Sep 1;127(5):1151-7. doi: 10.1002/ijc.25144.

3.

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD.

Cancer Res. 2006 Oct 15;66(20):10112-9.

4.

Age-related changes of the cervix influence human papillomavirus type distribution.

Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodríguez AC, Bratti MC, Hildesheim A, Wacholder S, Long LR, Neve L, Pfeiffer R, Burk RD.

Cancer Res. 2006 Jan 15;66(2):1218-24.

5.

A population-based study of vaginal human papillomavirus infection in hysterectomized women.

Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, Rodriguez AC, Wacholder S, Sherman ME, Kendall H, Viscidi RP, Jeronimo J, Schussler JE, Burk RD.

J Infect Dis. 2004 Aug 1;190(3):458-67. Epub 2004 Jul 2.

PMID:
15243917
6.

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.

Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D; HPV-039 study group.

Int J Cancer. 2014 Dec 1;135(11):2604-11. doi: 10.1002/ijc.28896. Epub 2014 May 20.

7.

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.

Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD.

Int J Cancer. 2007 Dec 15;121(12):2787-93.

8.

High prevalence of human papillomavirus type 58 in Mexican colposcopy patients.

González-Losa Mdel R, Rosado-Lopez I, Valdez-González N, Puerto-Solís M.

J Clin Virol. 2004 Mar;29(3):202-5.

PMID:
14962790
9.

Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment.

Stanczuk GA, Currie H, Baxter G, Foster A, Gibson L, Graham C, Cuschieri K.

J Clin Pathol. 2015 Jul;68(7):567-70. doi: 10.1136/jclinpath-2014-202851. Epub 2015 Apr 15.

PMID:
25878328
10.

Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.

Konno R, Tamura S, Dobbelaere K, Yoshikawa H.

Cancer Sci. 2011 Apr;102(4):877-82. doi: 10.1111/j.1349-7006.2011.01878.x. Epub 2011 Feb 17.

11.

Detection of human papillomavirus (HPV) genotypes in cervico-vaginal scrapes of women with normal and abnormal cytology.

Finan RR, Irani-Hakime N, Tamim H, Sharide HE, Daccache JL, Almawi WY.

Clin Microbiol Infect. 2001 Dec;7(12):688-92.

12.

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.

Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE.

J Clin Virol. 2006 Jul;36(3):189-93. Epub 2006 May 11.

PMID:
16690350
13.

Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville).

Boumba LM, Qmichou Z, Mouallif M, Attaleb M, El Mzibri M, Hilali L, Donatien M, Ennaji MM.

J Med Virol. 2015 Oct;87(10):1769-76. doi: 10.1002/jmv.24221. Epub 2015 May 11.

PMID:
25963674
14.

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.

Palmisano ME, Gaffga AM, Daigle J, Brinkman J, Mire K, Lenczyk K, Martin DH, Hagensee ME.

Int J STD AIDS. 2003 Aug;14(8):560-7.

PMID:
12935387
15.

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Cheung L, Wacholder S, Burk RD.

Int J Cancer. 2012 Oct 15;131(8):1874-81. doi: 10.1002/ijc.27418. Epub 2012 Feb 28.

16.

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.

Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14.

17.

Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.

Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS.

J Clin Microbiol. 2007 Oct;45(10):3245-50. Epub 2007 Aug 15.

18.

Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.

Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE; ASCUS-LSIL Triage Study Group.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):11-6.

19.

Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens.

Kapala J, Jang D, Patel J, Biers K, Smieja M, Chernesky M.

J Virol Methods. 2007 Jun;142(1-2):223-5. Epub 2007 Feb 23.

PMID:
17320978
20.

Supplemental Content

Support Center